New Monoclonal Antibody Fully Approved For The Treatment Of Covid-19
The Food and Drug Administration has approved Tocilizumab for use against moderate to severe Covid-19 symptoms.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & Source Type: news